Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (37)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Slater-Radosti, C.
Right arrow Articles by Jaworski, D. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Slater-Radosti, C.
Right arrow Articles by Jaworski, D. D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2001) 48, 1-6
© 2001 The British Society for Antimicrobial Chemotherapy

Biochemical and genetic characterization of the action of triclosan on Staphylococcus aureus

Courtney Slater-Radostia, Glenn Van Allera, Rebecca Greenwooda, Richard Nicholasa, Paul M. Kellerb, Walter E. DeWolf, Jrb, Frank Fana, David J. Paynea and Deborah D. Jaworskia,*

a Anti-Infectives Research, GlaxoSmithKline Pharmaceuticals, 1250 S. Collegeville Road, Collegeville, PA 19426; b Mechanistic Enzymology, GlaxoSmithKline Pharmaceuticals, 709 Swedeland Road, King of Prussia, PA 19406, USA

Triclosan, a widely used antibacterial agent, possesses potent activity against Staphylococcus aureus. This study reports on an investigation of the antibacterial target of triclosan in this pathogen. A strain of S. aureus overexpressing the enoyl-[acyl-carrier-protein] reductase (FabI), demonstrated by Western immunoblotting, gave rise to an increase in the MIC of triclosan, while susceptibilities to a range of unrelated antibacterials were unaffected. There are approximately 12 000 molecules of FabI per cell in mid-log phase growth. This number increased by approximately three- to four-fold in the S. aureus FabI overexpressor. Triclosan selectively inhibited the incorporation of [14C]acetate into TCA-precipitable product, an indicator of fatty acid biosynthesis. Furthermore, it inhibited de novo fatty acid biosynthesis in this organism. In vitro, triclosan inhibited recombinant, purified S. aureus FabI with an IC50 of approximately 1 µM. The combination of these biochemical and genetic data provide further evidence that the mode of action of triclosan in S. aureus is via inhibition of FabI.

* Corresponding author. Tel: +1-610-917-6368; Fax: +1-610-917-7901; E-mail: deb_d_jaworski{at}sbphrd.com


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
J. A. Karlowsky, N. Kaplan, B. Hafkin, D. J. Hoban, and G. G. Zhanel
AFN-1252, a FabI Inhibitor, Demonstrates a Staphylococcus-Specific Spectrum of Activity
Antimicrob. Agents Chemother., August 1, 2009; 53(8): 3544 - 3548.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
R. O. Darouiche, M. D. Mansouri, P. V. Gawande, and S. Madhyastha
Antimicrobial and antibiofilm efficacy of triclosan and DispersinB(R) combination
J. Antimicrob. Chemother., July 1, 2009; 64(1): 88 - 93.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
C. J. Zheng, M.-J. Sohn, and W.-G. Kim
Vinaxanthone, a new FabI inhibitor from Penicillium sp.
J. Antimicrob. Chemother., May 1, 2009; 63(5): 949 - 953.
[Abstract] [Full Text] [PDF]

Home page
 J Med MicrobiolHome page
L. Birosova and M. Mikulasova
Development of triclosan and antibiotic resistance in Salmonella enterica serovar Typhimurium
J. Med. Microbiol., April 1, 2009; 58(4): 436 - 441.
[Abstract] [Full Text] [PDF]

Home page
 Appl. Environ. Microbiol.Home page
Y. Chen, W. Deng, J. Wu, J. Qian, J. Chu, Y. Zhuang, S. Zhang, and W. Liu
Genetic Modulation of the Overexpression of Tailoring Genes eryK and eryG Leading to the Improvement of Erythromycin A Purity and Production in Saccharopolyspora erythraea Fermentation
Appl. Envir. Microbiol., March 15, 2008; 74(6): 1820 - 1828.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
N. Wolter, A. M. Smith, D. J. Farrell, J. B. Northwood, S. Douthwaite, and K. P. Klugman
Telithromycin Resistance in Streptococcus pneumoniae Is Conferred by a Deletion in the Leader Sequence of erm(B) That Increases rRNA Methylation
Antimicrob. Agents Chemother., February 1, 2008; 52(2): 435 - 440.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
T. Bogdanovich, C. Clark, K. Kosowska-Shick, B. Dewasse, P. McGhee, and P. C. Appelbaum
Antistaphylococcal Activity of CG400549, a New Experimental FabI Inhibitor, Compared with That of Other Agents
Antimicrob. Agents Chemother., November 1, 2007; 51(11): 4191 - 4195.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
H. S. Park, Y. M. Yoon, S. J. Jung, C. M. Kim, J. M. Kim, and J.-H. Kwak
Antistaphylococcal activities of CG400549, a new bacterial enoyl-acyl carrier protein reductase (FabI) inhibitor
J. Antimicrob. Chemother., September 1, 2007; 60(3): 568 - 574.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
T. Fleck, R. Moidl, A. Blacky, M. Fleck, E. Wolner, M. Grabenwoger, and W. Wisser
Triclosan-Coated Sutures for the Reduction of Sternal Wound Infections: Economic Considerations
Ann. Thorac. Surg., July 1, 2007; 84(1): 232 - 236.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
R. Bayston, W. Ashraf, and T. Smith
Triclosan resistance in methicillin-resistant Staphylococcus aureus expressed as small colony variants: a novel mode of evasion of susceptibility to antiseptics
J. Antimicrob. Chemother., May 1, 2007; 59(5): 848 - 853.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
C. V. Hawkyard and R. J. Koerner
The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks
J. Antimicrob. Chemother., March 1, 2007; 59(3): 347 - 358.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
N. Wolter, A. M. Smith, D. E. Low, and K. P. Klugman
High-Level Telithromycin Resistance in a Clinical Isolate of Streptococcus pneumoniae
Antimicrob. Agents Chemother., March 1, 2007; 51(3): 1092 - 1095.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
P. F. Seaman, D. Ochs, and M. J. Day
Small-colony variants: a novel mechanism for triclosan resistance in methicillin-resistant Staphylococcus aureus
J. Antimicrob. Chemother., January 1, 2007; 59(1): 43 - 50.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
S. Takahata, M. Iida, Y. Osaki, J. Saito, H. Kitagawa, T. Ozawa, T. Yoshida, and S. Hoshiko
AG205, a Novel Agent Directed against FabK of Streptococcus pneumoniae.
Antimicrob. Agents Chemother., August 1, 2006; 50(8): 2869 - 2871.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
E. T. Buurman, B. Andrews, A. E. Blodgett, J. S. Chavda, and N. F. Schnell
Utilization of Target-Specific, Hypersensitive Strains of Saccharomyces cerevisiae To Determine the Mode of Action of Antifungal Compounds
Antimicrob. Agents Chemother., June 1, 2005; 49(6): 2558 - 2560.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
M. G. Escalada, J. L. Harwood, J.-Y. Maillard, and D. Ochs
Triclosan inhibition of fatty acid synthesis and its effect on growth of Escherichia coli and Pseudomonas aeruginosa
J. Antimicrob. Chemother., June 1, 2005; 55(6): 879 - 882.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
G. Kampf and A. Kramer
Epidemiologic Background of Hand Hygiene and Evaluation of the Most Important Agents for Scrubs and Rubs
Clin. Microbiol. Rev., October 1, 2004; 17(4): 863 - 893.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
Y. Q. Liu, Y. Z. Zhang, and P. J. Gao
Novel Concentration-Killing Curve Method for Estimation of Bactericidal Potency of Antibiotics in an In Vitro Dynamic Model
Antimicrob. Agents Chemother., October 1, 2004; 48(10): 3884 - 3891.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
R. R. Reinert
Clinical efficacy of ketolides in the treatment of respiratory tract infections
J. Antimicrob. Chemother., June 1, 2004; 53(6): 918 - 927.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
M. B. Schmid and N. Kaplan
Reduced Triclosan Susceptibility in Methicillin-Resistant Staphylococcus epidermidis
Antimicrob. Agents Chemother., April 1, 2004; 48(4): 1397 - 1399.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
S. Sharma, T. N. C. Ramya, A. Surolia, and N. Surolia
Triclosan as a Systemic Antibacterial Agent in a Mouse Model of Acute Bacterial Challenge
Antimicrob. Agents Chemother., December 1, 2003; 47(12): 3859 - 3866.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
M. R. Jacobs, S. Bajaksouzian, and P. C. Appelbaum
Telithromycin post-antibiotic and post-antibiotic sub-MIC effects for 10 Gram-positive cocci
J. Antimicrob. Chemother., November 1, 2003; 52(5): 809 - 812.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
Z. Al-Doori, D. Morrison, G. Edwards, and C. Gemmell
Susceptibility of MRSA to triclosan
J. Antimicrob. Chemother., January 1, 2003; 51(1): 185 - 186.
[Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
A. R. Reeves, G. Weber, W. H. Cernota, and J. M. Weber
Analysis of an 8.1-kb DNA Fragment Contiguous with the Erythromycin Gene Cluster of Saccharopolyspora erythraea in the eryCI-Flanking Region
Antimicrob. Agents Chemother., December 1, 2002; 46(12): 3892 - 3899.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
F. Fan, K. Yan, N. G. Wallis, S. Reed, T. D. Moore, S. F. Rittenhouse, W. E. DeWolf Jr., J. Huang, D. McDevitt, W. H. Miller, et al.
Defining and Combating the Mechanisms of Triclosan Resistance in Clinical Isolates of Staphylococcus aureus
Antimicrob. Agents Chemother., November 1, 2002; 46(11): 3343 - 3347.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
D. J. Payne, W. H. Miller, V. Berry, J. Brosky, W. J. Burgess, E. Chen, W. E. DeWolf Jr., A. P. Fosberry, R. Greenwood, M. S. Head, et al.
Discovery of a Novel and Potent Class of FabI-Directed Antibacterial Agents
Antimicrob. Agents Chemother., October 1, 2002; 46(10): 3118 - 3124.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
R. Leclercq and P. Courvalin
Resistance to Macrolides and Related Antibiotics in Streptococcus pneumoniae
Antimicrob. Agents Chemother., September 1, 2002; 46(9): 2727 - 2734.
[Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
S. M. Finegold, D. Molitoris, V. T. Phan, M.-L. Vaisanen, and H. M. Wexler
Activities of ABT-773 against Microaerophilic and Fastidious Organisms
Antimicrob. Agents Chemother., August 1, 2002; 46(8): 2716 - 2719.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
D. E. Low, J. de Azavedo, K. Weiss, T. Mazzulli, M. Kuhn, D. Church, K. Forward, G. Zhanel, A. Simor, and A. McGeer
Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae in Canada during 2000
Antimicrob. Agents Chemother., May 1, 2002; 46(5): 1295 - 1301.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
P. M. Shah
Determination of MICs in the routine laboratory
J. Antimicrob. Chemother., December 1, 2001; 48(6): 931 - 931.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.